Literature DB >> 26229400

Restraint stress induces and exacerbates intestinal inflammation in interleukin-10 deficient mice.

Seong-Joon Koh1, Ji Won Kim1, Byeong Gwan Kim1, Kook Lae Lee1, Joo Sung Kim1.   

Abstract

AIM: To investigate the effects of restraint stress on chronic colitis in interleukin (IL)-10 deficient (IL-10(-/-)) mice.
METHODS: The first experiment compared the effect of restraint stress on the development of intestinal inflammation in wild-type and IL-10(-/-) mice. Both wild-type and IL-10(-/-) mice were physically restrained in a well-ventilated, 50 cm(3) conical polypropylene tube for 2 h per day for three consecutive days. The second experiment was performed to assess the effect of restraint stress on exacerbation of colitis induced by piroxicam in IL-10(-/-) mice. The IL-10(-/-) mice were exposed to restraint stress for 2 h per day for 3 consecutive days, and then treated with piroxicam for 4 d at a dose of 200 ppm administered in the rodent chow.
RESULTS: In the first experiment, none of the wild-type mice with or without restraint stress showed clinical and histopathological abnormality in the gut. However, IL-10(-/-) mice exposed to restraint stress exhibited histologically significant intestinal inflammation as compared to those without restraint stress. In the second experiment, restraint stress significantly reduced body weight and increased the severity of intestinal inflammation assessed by histopathologic grading in IL-10(-/-) mice. Colonic IL12p40 mRNA expression was strongly increased in mice exposed to restraint stress.
CONCLUSION: This novel animal model could be useful in future study of psychological stress in the pathogenesis of inflammatory bowel disease.

Entities:  

Keywords:  Colitis; Inflammatory bowel disease; Interleukin-10; Mouse model; Stress

Mesh:

Substances:

Year:  2015        PMID: 26229400      PMCID: PMC4515839          DOI: 10.3748/wjg.v21.i28.8580

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Oxidative stress, vitamin A and vitamin E behaviour in patients submitted to conservative surgery for complicated Crohn's disease.

Authors:  G M Sampietro; M Cristaldi; G Cervato; G Maconi; P Danelli; R Cervellione; M Rovati; G Bianchi Porro; B Cestaro; A M Taschieri
Journal:  Dig Liver Dis       Date:  2002-10       Impact factor: 4.088

Review 2.  Inflammatory bowel disease: cause and immunobiology.

Authors:  Daniel C Baumgart; Simon R Carding
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

3.  Rapid development of colitis in NSAID-treated IL-10-deficient mice.

Authors:  Daniel J Berg; Juan Zhang; Joel V Weinstock; Hanan F Ismail; Keith A Earle; Hector Alila; Rifat Pamukcu; Steven Moore; Richard G Lynch
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

4.  Fexofenadine regulates nuclear factor-κB signaling and endoplasmic reticulum stress in intestinal epithelial cells and ameliorates acute and chronic colitis in mice.

Authors:  Seong-Joon Koh; Ji Won Kim; Byeong Gwan Kim; Kook Lae Lee; Jaeyoung Chun; Joo Sung Kim
Journal:  J Pharmacol Exp Ther       Date:  2014-12-23       Impact factor: 4.030

5.  Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice.

Authors:  Seong-Joon Koh; Jung Mogg Kim; In-Kyoung Kim; Nayoung Kim; Hyun Chae Jung; In Sung Song; Joo Sung Kim
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-24       Impact factor: 4.052

6.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

7.  IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice.

Authors:  N J Davidson; S A Hudak; R E Lesley; S Menon; M W Leach; D M Rennick
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

8.  Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.

Authors:  Laurens Kruidenier; Ineke Kuiper; Cornelis B H W Lamers; Hein W Verspaget
Journal:  J Pathol       Date:  2003-09       Impact factor: 7.996

Review 9.  The shifting interface between IBS and IBD.

Authors:  Robin Spiller; Ching Lam
Journal:  Curr Opin Pharmacol       Date:  2011-10-13       Impact factor: 5.547

10.  Effects of Hypericum perforatum extract on rat irritable bowel syndrome.

Authors:  Shilan Mozaffari; Hadi Esmaily; Roja Rahimi; Maryam Baeeri; Yara Sanei; Azar Asadi-Shahmirzadi; Mohammad-Hossein Salehi-Surmaghi; Mohammad Abdollahi
Journal:  Pharmacogn Mag       Date:  2011-07       Impact factor: 1.085

View more
  5 in total

Review 1.  Visceral Inflammation and Immune Activation Stress the Brain.

Authors:  Peter Holzer; Aitak Farzi; Ahmed M Hassan; Geraldine Zenz; Angela Jačan; Florian Reichmann
Journal:  Front Immunol       Date:  2017-11-22       Impact factor: 7.561

2.  Restraint devices for repetitive transcranial magnetic stimulation in mice and rats.

Authors:  Chengliang Zhang; Rulan Lu; Linxiao Wang; Wenwei Yun; Xianju Zhou
Journal:  Brain Behav       Date:  2019-04-29       Impact factor: 2.708

Review 3.  Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults.

Authors:  Yue Sun; Lu Li; Runxiang Xie; Bangmao Wang; Kui Jiang; Hailong Cao
Journal:  Front Pediatr       Date:  2019-10-24       Impact factor: 3.418

4.  Repetitive stress in mice causes migraine-like behaviors and calcitonin gene-related peptide-dependent hyperalgesic priming to a migraine trigger.

Authors:  Amanda Avona; Bianca N Mason; Jacob Lackovic; Naureen Wajahat; Marina Motina; Lilyana Quigley; Carolina Burgos-Vega; Cristina Moldovan Loomis; Leon F Garcia-Martinez; Armen N Akopian; Theodore J Price; Gregory Dussor
Journal:  Pain       Date:  2020-11       Impact factor: 7.926

5.  Role of melatonin in intestinal mucosal injury induced by restraint stress in mice.

Authors:  Rutao Lin; Zixu Wang; Jing Cao; Ting Gao; Yulan Dong; Yaoxing Chen
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.